Feasibility of Non-Operative Management of Rectal Cancer in a Rural Population
Part of paid clinical trials in Cooperstown, New York.
- Sponsor
- Bassett Healthcare
- Study ID
- NCT04245683
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Bowel/rectal resection — PROCEDUREsurgical removal of the portion of the rectum where the tumor was originally identified
- non-operative follow up — OTHERpatients who choose the non-operative option will be required to adhere to a very intensive follow up protocol, including endoscopy and CT imaging
Study Details
This is an observational research study. Patients with rectal cancer can choose different courses of treatment. This study will follow these patients over the course of approximately six years, depending on their treatment. Patients will be monitored through clinic visits and survey assessments to see how they do, how they feel regarding their treatment choices, and their outcomes. The surveys will analyze the impact of the patients' treatment choices, as well as patient adherence, in a rural setting.
Key Dates
- Start date
- Feb 1, 2020
- Status verified
- Mar 2023
- Primary completion
- Feb 1, 2027
- Completion
- Aug 1, 2027
Study Design
- Enrollment
- 50 participants (estimated)
Arms
- Arm: Operative GroupPatients who select operative treatment and follow up after successful neoadjuvant treatment.
- Arm: Non-operative GroupPatients who select non-operative follow up after successful neoadjuvant treatment
Primary Outcome Measure
patient preferences for operative vs. non-operative management of rectal cancer [ Time Frame: 8 months ]
Central Contacts
- Jennifer Victory, RN6075476965
- Katelyn Tessier607-547-3073
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Bassett Healthcare Network | Cooperstown | New York | 13326 | Eric Bravin, MD (PRINCIPAL_INVESTIGATOR) Raul Monzon, MD (SUB_INVESTIGATOR) Luis Oceguera, MD (SUB_INVESTIGATOR) Marcy Canary, MD (SUB_INVESTIGATOR) Bharatsinh Gharia, MD (SUB_INVESTIGATOR) Bryan Lee, DO (SUB_INVESTIGATOR) James Leonardo, MD (SUB_INVESTIGATOR) Anush Patel, MD (SUB_INVESTIGATOR) Timothy Korytko, MD (SUB_INVESTIGATOR) Julia Manzerova, MD (SUB_INVESTIGATOR) Alfred Tinger, MD (SUB_INVESTIGATOR) |
Find similar trials in Cooperstown, NY
By condition
By specialty
By research site
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Efficacy and Safety of the CG-100 Intraluminal Bypass DeviceRecruiting · Colospan Ltd. · Orange, California
- A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.PHASE2 · Recruiting · Weill Medical College of Cornell University · New York, New York
- A Study of Tucatinib and Trastuzumab in People With Rectal CancerPHASE2 · Recruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey